Company intelligence / Profile preview

Diabeto

New York City, New York, United Statesx.com ↗

Ownership: Private
Development stage: Commercial

Overview

Diabeto developed a hardware device ("Birdie") that connects over 40 different glucose meters to mobile apps, enabling seamless transfer of blood glucose data for people with diabetes. The solution aimed to make it easier and more affordable for patients and healthcare providers to manage diabetes by integrating existing devices with digital platforms. In September 2017, Diabeto was acquired by Livongo Health, which integrated its connectivity solutions into Livongo’s broader digital care management platform[2].

Therapeutic areas: Endocrinology
Modalities: DeviceSoftware
Industry: Digital Health Medical Devices

Partnerships

Livongo Health partnership/acquisition

Beyond the preview

Go deeper on Diabeto.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Diabeto.

Explore the full profile